Request Deal Involvement
Valeant Pharmaceuticals and Pershing Square failed to acquire Allergan for $52bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Latham & Watkins
legal advisors
Richards Layton and Finger
financial advisors
Bank of America
financial advisors
Goldman Sachs
pr advisors
Joele Frank
debt providers
Barclays
debt providers
RBC Capital Markets
pr advisors
Sard Verbinnen & Co
legal advisors
Osler Hoskin & Harcourt
financial advisors
RBC Capital Markets
legal advisors
Davies Ward Phillips & Vineberg
legal advisors
Kirkland & Ellis
legal advisors
Skadden Arps Slate Meagher & Flom
legal advisors
Sullivan & Cromwell
financial advisors
Barclays
financial advisors
Credit Suisse
or
Principals
target
ALLERGAN PLC
bidder
VALEANT PHARMACEUTICALS
bidder
PERSHING SQUARE CAPITAL MANAGEMENT LP
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite